STAQ Pharma, Inc. FDA Record
- Latest inspection VAI · Feb 10, 2025
- 2 Class I recalls
- No warning letters matched by name
STAQ Pharma, Inc. has 6 FDA recalls (2 Class I), 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "STAQ Pharma, Inc." is on file. FDA has published 2 Form 483s for STAQ Pharma, Inc..
- Latest recall
- D-0023-2026 · Class III · Oct 9, 2025
- Latest inspection
- Feb 10, 2025 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 6 (2 Class I) | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 3 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
STAQ Pharma, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 3 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 1 | 0 |
| 2022 | 0 | 0 | 0 | 2 | 2 |
| 2021 | 1 | 0 | 0 | 0 | 0 |
| 2020 | 1 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing STAQ Pharma, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check STAQ Pharma, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
STAQ Pharma, Inc. Form 483s
| Date | Document | FEI |
|---|---|---|
| Sep 29, 2021 · Document on fda.gov | 483 | 3015144909 |
| Sep 3, 2020 · Document on fda.gov | 483 | 3015144909 |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0023-2026 | Class III | Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ… | Oct 9, 2025 |
| D-0024-2026 | Class III | Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc… | Oct 9, 2025 |
| D-0025-2026 | Class III | FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ… | Oct 9, 2025 |
| D-0147-2024 | Class II | ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL bags, Rx… | Nov 29, 2023 |
| D-0633-2022 | Class I | HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only… | Feb 3, 2022 |
| D-0634-2022 | Class I | Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ… | Feb 3, 2022 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Feb 10, 2025 | Denver, CO | Drugs | Voluntary Action Indicated (VAI) | 3015144909 |
| Sep 29, 2021 | Denver, CO | Drugs | Voluntary Action Indicated (VAI) | 3015144909 |
| Sep 3, 2020 | Denver, CO | Drugs | Voluntary Action Indicated (VAI) | 3015144909 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3015144909 | Denver, CO | 3 | Feb 10, 2025 |
STAQ Pharma, Inc. and the FDA: common questions
Has STAQ Pharma, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "STAQ Pharma, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has STAQ Pharma, Inc. received an FDA Form 483?
FDA has published 2 Form 483s for STAQ Pharma, Inc. in its reading room, the most recent dated Sep 29, 2021. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect STAQ Pharma, Inc.?
The most recent FDA inspection on file ended Feb 10, 2025 at Denver, CO and was classified VAI. FDA has 3 inspections of STAQ Pharma, Inc. on file.
Has STAQ Pharma, Inc. had an FDA recall?
Yes. STAQ Pharma, Inc. has 6 FDA recalls on record, 2 of them Class I, the most serious class. The most recent started Oct 9, 2025.
Need more than this page shows? Ask about STAQ Pharma, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.